Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3035-3046
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3035
Table 3 Comparison of coagulation indicators between two groups at different points in time

Control (n = 128)
Early warning (n = 136)
P value
d-dimer (µg/mL), mean ± SD
Before0.46 ± 0.200.44 ± 0.240.473
1 d1.86 ± 0.962.04 ± 1.270.197
3 d3.27 ± 1.852.68 ± 1.740.008
7 d2.75 ± 1.821.52 ± 1.030.000
Prothrombin time (s), mean ± SD
Before11.3 ± 1.411.1 ± 1.00.061
1 d11.5 ± 1.111.3 ± 1.20.359
3 d11.7 ± 1.011.5 ± 0.90.057
7 d11.2 ± 1.211.3 ± 1.00.648
Fibrinogen degradation product, mean ± SD
Before2.54 ± 1.522.67 ± 1.360.464
1 d7.26 ± 3.216.82 ± 3.290.273
3 d7.69 ± 2.275.62 ± 2.110.000
7 d8.16 ± 4.264.38 ± 3.040.000
Activated partial thromboplastin time (s), mean ± SD
Before33.1 ± 6.432.2 ± 5.70.242
1 d35.6 ± 7.335.7 ± 6.60.925
3 d34.6 ± 6.632.8 ± 7.30.523
7 d62.3 ± 6.332.3 ± 6.60.247